- Antiviral Susceptibility Reference Unit General
- ARMHAI Reference Lab
- BBVU
- BBVU & NHSBT (General)
- Bristol Mycology Reference Laboratory General
- Business Strategy
- Commercial Ops
- Covid Testing Device Approvals Team
- Media
- Papilloma Reference Unit
- RCGP Study / PCR Testing
- Respiratory Virus Unit
- RVPBRU
- UK Health Security Agency
- UK Health Security Agency
- Clinical & Public Health
- Clinical & Public Health
- Clinical and Emerging Infections
- Genomics
- Health Equity & Clinical Governance
- Public Health programmes
- Covid Vaccine Unit
- Data, Analytics Surveillance
- All Hazards Intelligence
- Analytics & Data Sciences
- Covid Surveillance
- Cyber Security
- Data Operations
- DG Office
- Strategy Design & Delivery
- Health Protection Operations
- Field Services
- Global Public Health
- HPO Assurance Change & Transformation
- HPO DG Private Office
- HPO Emergency Preparedness, Resilience & Response
- National Operations
- Pan Regional
- Response Operations
- Science
- Diagnostics & Innovation
- Epidemiological and Behavioural Sciences
- Radiation, Chemical & Environmental Hazards
- Science Group Business Management & PMO
- Scientific Strategy & Development
- Specialised Microbiology & Laboratories
- Colindale Site, Support functions, National Standards, Products and Services,Quality and Safety
- Genomics Service Delivery & Quality
- High Containment and Biological Services
- Lab Network & NHS Liaison
- Porton Site
- Reference Services
- Research & Evaluation
- Specialised Microbiology & Laboratories
- Clinical & Public Health
- UKHSA Academic Honorary staff
- Vaccine Preventable Viruses Unit
- Variants of Concern and monitoring
- Virology
- Virus Reference Department General